GLP-1 medication GLP-1 medication · Easy
Foundayo (orforglipron)
The first oral non peptide GLP1 agonist, approved in April 2026 and taken daily without food or water timing rules.
- Goal
- Weight loss
As published
| Generic name | orforglipron |
|---|---|
| Brand | Foundayo |
| Route | oral |
| Schedule as published | daily, 0.8 then 2.5 then 5.5 mg in steps of 30 days or more, optional 9, 14.5 or 17.2 mg |
Factual entries only, as published by the maker. Undiet does not suggest a medication, a dose or a schedule. Talk to your doctor.
In Undiet
Foundayo (orforglipron) is a GLP-1 medication in the Undiet catalog. Marking it records what you are already doing: a self-report marker, never a recommendation. From that day it is a period on your timeline, with your weight and how the days felt drawn across it, and what happens after you stop kept as a period of its own.
Mark it in UndietFree on iPhone and AndroidRelated programs
On iPhone and Android
Start with today.
Free on iPhone and Android. Mark Foundayo (orforglipron) and the first period of your timeline begins.
Download on the App StoreGet it on Google Play